| Product Code: ETC7546462 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India large volume parenteral market import shipment experienced a significant decline with a CAGR of -13.8% from 2020 to 2024. However, there was a slight moderation in the negative growth rate between 2023 and 2024, showing signs of stabilization amid the overall downward trend in the market.
The India Large Volume Parenteral (LVP) Market is experiencing significant growth due to the increasing demand for injectable pharmaceuticals and the rising prevalence of chronic diseases in the country. LVPs are sterile solutions intended for intravenous administration and are used for various medical conditions such as dehydration, electrolyte imbalance, and nutrient supplementation. Key players in the market are focusing on product innovation, quality assurance, and expanding their distribution networks to cater to the growing healthcare needs of the population. The market is highly regulated by government authorities to ensure the safety and efficacy of these critical healthcare products. Additionally, technological advancements in production processes and packaging materials are further driving market growth and enhancing the overall efficiency of LVP products.
The India Large Volume Parenteral (LVP) market is experiencing steady growth due to factors such as increasing prevalence of chronic diseases, rising geriatric population, and improving healthcare infrastructure. Key trends in the market include a growing demand for ready-to-use LVPs, advancements in technology for drug delivery systems, and increasing focus on quality control and regulatory compliance. Opportunities in the market lie in the expansion of product portfolios by pharmaceutical companies, strategic partnerships and collaborations to enhance market presence, and investments in research and development for innovative LVP solutions. With the government`s focus on universal healthcare access and the ongoing COVID-19 pandemic highlighting the importance of healthcare preparedness, the India LVP market is poised for further growth and development in the coming years.
In the India Large Volume Parenteral (LVP) market, some key challenges include regulatory hurdles, pricing pressure, and quality control issues. The regulatory environment in India can be complex and stringent, requiring LVP manufacturers to navigate various approval processes and compliance requirements. Additionally, intense competition in the market leads to pricing pressures, impacting profit margins for companies. Ensuring the quality and safety of LVP products is also a significant challenge, as maintaining strict standards throughout the manufacturing and distribution processes is crucial to avoid contamination or other risks to patient health. Overall, companies operating in the India LVP market need to address these challenges effectively to succeed in this competitive and highly regulated industry.
The India Large Volume Parenteral Market is primarily driven by increasing prevalence of chronic diseases requiring parenteral administration of medications, rising geriatric population in need of advanced medical treatments, growing demand for efficient drug delivery systems, and expanding healthcare infrastructure in the country. Furthermore, the shift towards home healthcare services and rising awareness about the benefits of large volume parenteral products are also contributing to the market growth. Additionally, advancements in technology, such as the introduction of innovative drug delivery devices and formulations, are further propelling the market forward. Overall, the increasing focus on providing accessible and effective healthcare solutions is fueling the demand for large volume parenteral products in India.
The India Large Volume Parenteral (LVP) market is subject to various government policies and regulations aimed at ensuring quality, safety, and affordability of these essential medical products. The National Pharmaceutical Pricing Authority (NPPA) regulates the prices of LVPs to make them accessible to the general population. The Drugs Controller General of India (DCGI) oversees the approval and regulation of LVPs to maintain quality standards and safety for patients. Additionally, the government encourages domestic manufacturing of LVPs through initiatives such as Make in India to reduce dependence on imports and promote self-sufficiency in healthcare products. These policies collectively shape the landscape of the India LVP market, emphasizing affordability, quality, and domestic production.
The India Large Volume Parenteral (LVP) market is expected to witness steady growth in the coming years due to the increasing demand for injectable drugs and intravenous solutions across healthcare facilities in the country. Factors such as rising prevalence of chronic diseases, expanding geriatric population, and growing emphasis on quality healthcare services are driving the market. Additionally, advancements in technology, regulatory reforms, and increasing investments in healthcare infrastructure will further fuel market growth. However, challenges such as stringent regulatory requirements and pricing pressures may hinder the market expansion to some extent. Overall, with the government`s focus on improving healthcare accessibility and quality, coupled with evolving healthcare needs of the population, the India LVP market is poised for positive growth prospects in the foreseeable future.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Large Volume Parenteral Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Large Volume Parenteral Market Revenues & Volume, 2021 & 2031F |
3.3 India Large Volume Parenteral Market - Industry Life Cycle |
3.4 India Large Volume Parenteral Market - Porter's Five Forces |
3.5 India Large Volume Parenteral Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 India Large Volume Parenteral Market Revenues & Volume Share, By Volume, 2021 & 2031F |
3.7 India Large Volume Parenteral Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 India Large Volume Parenteral Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 India Large Volume Parenteral Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 India Large Volume Parenteral Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in India leading to higher demand for large volume parenteral products |
4.2.2 Growing healthcare infrastructure and increasing government initiatives to improve healthcare services |
4.2.3 Rising geriatric population in India requiring more medical interventions and treatments |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements and compliance standards impacting the production and distribution of large volume parenteral products |
4.3.2 High cost associated with large volume parenteral products leading to affordability issues for some segments of the population |
4.3.3 Limited awareness and adoption of large volume parenteral products in certain regions of India |
5 India Large Volume Parenteral Market Trends |
6 India Large Volume Parenteral Market, By Types |
6.1 India Large Volume Parenteral Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 India Large Volume Parenteral Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 India Large Volume Parenteral Market Revenues & Volume, By Soft Bag LVP, 2021- 2031F |
6.1.4 India Large Volume Parenteral Market Revenues & Volume, By Plastic Bottle LVP, 2021- 2031F |
6.1.5 India Large Volume Parenteral Market Revenues & Volume, By Glass Bottle LVP, 2021- 2031F |
6.2 India Large Volume Parenteral Market, By Volume |
6.2.1 Overview and Analysis |
6.2.2 India Large Volume Parenteral Market Revenues & Volume, By 100 ml-250 ml, 2021- 2031F |
6.2.3 India Large Volume Parenteral Market Revenues & Volume, By 250 ml-500 ml, 2021- 2031F |
6.2.4 India Large Volume Parenteral Market Revenues & Volume, By 500 ml-1000 ml, 2021- 2031F |
6.2.5 India Large Volume Parenteral Market Revenues & Volume, By 1000 ml-2000 ml, 2021- 2031F |
6.2.6 India Large Volume Parenteral Market Revenues & Volume, By 2000 ml and more, 2021- 2031F |
6.3 India Large Volume Parenteral Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 India Large Volume Parenteral Market Revenues & Volume, By Therapeutic Injections, 2021- 2031F |
6.3.3 India Large Volume Parenteral Market Revenues & Volume, By Fluid Balance Injections, 2021- 2031F |
6.3.4 India Large Volume Parenteral Market Revenues & Volume, By Nutritious Injections, 2021- 2031F |
6.4 India Large Volume Parenteral Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 India Large Volume Parenteral Market Revenues & Volume, By Clinic, 2021- 2031F |
6.4.3 India Large Volume Parenteral Market Revenues & Volume, By Hospital, 2021- 2031F |
6.4.4 India Large Volume Parenteral Market Revenues & Volume, By Others, 2021- 2031F |
6.5 India Large Volume Parenteral Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 India Large Volume Parenteral Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 India Large Volume Parenteral Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.5.4 India Large Volume Parenteral Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 India Large Volume Parenteral Market Import-Export Trade Statistics |
7.1 India Large Volume Parenteral Market Export to Major Countries |
7.2 India Large Volume Parenteral Market Imports from Major Countries |
8 India Large Volume Parenteral Market Key Performance Indicators |
8.1 Percentage increase in the number of hospitals and healthcare facilities using large volume parenteral products |
8.2 Rate of adoption of advanced technology and automation in the production and distribution of large volume parenteral products |
8.3 Number of collaborations and partnerships between pharmaceutical companies and healthcare providers for the promotion of large volume parenteral products |
9 India Large Volume Parenteral Market - Opportunity Assessment |
9.1 India Large Volume Parenteral Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 India Large Volume Parenteral Market Opportunity Assessment, By Volume, 2021 & 2031F |
9.3 India Large Volume Parenteral Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 India Large Volume Parenteral Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 India Large Volume Parenteral Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 India Large Volume Parenteral Market - Competitive Landscape |
10.1 India Large Volume Parenteral Market Revenue Share, By Companies, 2024 |
10.2 India Large Volume Parenteral Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |